Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders
Launched by NEUROLOGICAL INSTITUTE OF ATHENS · Dec 18, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (MES-CoBraD) is a clinical trial aimed at improving the diagnosis and treatment of various brain-related conditions such as dementia, Alzheimer’s disease, epilepsy, and sleep disorders. Researchers are gathering real-world data from different sources to better understand these conditions and how they affect people’s lives. The goal is to create a more precise and personalized approach to care that enhances the quality of life for patients and their caregivers. This project involves a diverse team of experts from various fields, working together to ensure that everyone, including vulnerable communities, has access to better healthcare solutions.
If you're considering participating in this trial, you would need to visit one of three specialized clinics focused on epilepsy, neurocognitive disorders, or sleep disorders. The study is open to anyone willing to undergo a thorough assessment, including healthy volunteers. As a participant, you can expect to be part of a project that aims to make a real difference in the lives of people facing these complex brain disorders. The trial is currently recruiting participants of all ages and genders, making it an inclusive opportunity for many.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants willing to undergo comprehensive assessment who visit one of three clinics (Epilepsy, Neurocognitive disorders, and Sleep Disorders), and healthy volunteers
- Exclusion Criteria:
- • participant disinterest
About Neurological Institute Of Athens
The Neurological Institute of Athens is a leading research and clinical organization dedicated to advancing the understanding and treatment of neurological disorders. With a commitment to innovative research and patient-centered care, the institute conducts a range of clinical trials aimed at evaluating new therapies and interventions in neurology. The team comprises renowned neurologists, researchers, and healthcare professionals who collaborate to enhance therapeutic outcomes and improve the quality of life for individuals affected by neurological conditions. Through rigorous scientific inquiry and adherence to ethical standards, the Neurological Institute of Athens strives to contribute significantly to the field of neurology and to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Petah Tikva, , Israel
London, , United Kingdom
Athens, , Greece
Barcelona, , Spain
Patients applied
Trial Officials
Elissaios Karageorgiou
Study Director
Neurological Institute of Athens
Ioannis Stavropoulos
Study Director
King's College London
Ophir Keret
Study Director
Rabin Medical Center
Juan Fortea
Study Director
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials